Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Kintara Therapeutics Q2 EPS $(2.10) Beats $(3.16) Estimate

Kintara Therapeutics (NASDAQ:KTRA) reported quarterly losses of $(2.10) per share which beat the analyst consensus estimate of $(3.16) by 33.54 percent. This is a 65 percent increase over losses of $(6.00) per share from
byMichael Horton
February 14, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Kintara Therapeutics (NASDAQ:KTRA) reported quarterly losses of $(2.10) per share which beat the analyst consensus estimate of $(3.16) by 33.54 percent. This is a 65 percent increase over losses of $(6.00) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

5 Value Stocks In The Utilities Sector

By Benzinga Insights
September 28, 10:50 AM
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

CEPU